TT400002LentiTran, a transfection reagent for high titer lentivirusproduction, 1 mLsee attached… and 2 more items

The University of Virginia awarded contract A207_PO-0300005-V3 to OriGene Technologies Inc on August 8, 2026, for the provision of laboratory reagents and related services. The contract encompasses the supply of specialized transfection reagents required for viral vector production and cellular transfection applications. Specifically, the award includes 196 units of TT400002 LentiTran transfection reagent (1 milliliter per unit) for high-titer lentivirus production and 371 units of TF81001 TurboFectin Transfection Reagent (1 milliliter per vial). The total cumulative contract value is $567.

The line items are to be delivered to the University of Virginia's buyer in Virginia. In addition to the reagent supplies, the contract includes shipping costs as specified in the referenced quotation QA142065. The contracted materials represent consumable laboratory supplies necessary for advanced biological research and development activities conducted by the University of Virginia.